Oral mucosal electroporation device and use thereof
The present invention relates to electroporation (EP) devices that are able to generate an electroporation causing electrical field at the mucosal layer, and preferably in a tolerable manner. Further, it includes the generation of a protective immune response, cellular and/or humoral, using the oral EP device along with a genetic construct that encodes an immunogenic sequence.
1. A method of electroporating cells of a mucosal membrane of a mammal, wherein the method comprises:
contacting the mucosal membrane with a plurality of microneedles of an electrode microneedle plate, wherein the electrode microneedle plate is coupled to a housing;
positioning a voltage return electrode in contact with an opposite side of the mucosal membrane that is across from the electrode microneedle plate;
delivering a pharmaceutical solution from a reservoir, through the housing, through the electrode microneedle plate, and into the mucosal membrane, wherein delivering the pharmaceutical solution further comprises actuating a piston located remote from the reservoir and interposed between the reservoir and the electrode microneedle plate;
generating an electric potential at an energy source, wherein the electric potential is sufficient to electroporate the cells; and
delivering at least one pulse of electrical energy having the electric potential from the energy source, through the electrode microneedle plate, through the mucosal membrane, and through the voltage return electrode.
2. The method of claim 1 , further comprising storing the pharmaceutical solution in the reservoir prior to delivering the pharmaceutical solution.
3. The method of claim 2 , wherein the plurality of microneedles are made from electrically conductive materials comprising gold and silver plated brass, gold and silver plated copper, stainless steel, or titanium.
4. The method of claim 1 , wherein actuating the piston causes an even distribution of the pharmaceutical solution through the electrode microneedle plate.
5. The method of claim 1 , wherein the at least one pulse is delivered to the cells and is from 1 Volt to 30 Volts.
6. The method of claim 5 , wherein the at least one pulse has a current from 2 mAmp to 100 mAmp.
7. The method of claim 5 , wherein the at least one pulse has a duration from 1 millisecond to 250 milliseconds.
8. The method of claim 1 , wherein the mucosal membrane comprises buccal, nasal, esophageal, rectal, vaginal, vulva, intestinal, bowel, stomach, bladder, urinary tract, or eye tissue.
9. The method of claim 1 , wherein contacting the mucosal membrane comprises contacting the electrode microneedle plate to an inner surface of a mouth of said mammal.
10. The method of claim 1 , wherein the housing includes an arm moveable with respect to the electrode microneedle plate, and the voltage return electrode is coupled to the arm.
11. The method of claim 1 , wherein the piston faces the electrode microneedle plate so as to define a manifold area therebetween, and actuating the piston drives the pharmaceutical solution through the electrode microneedle plate.
12. The method of claim 11 , wherein the piston carries a sealing o-ring in contact with an interior of the main housing.
13. The method of claim 1 , further comprising locking the reservoir to the housing.
14. The method of claim 13 , wherein the reservoir is a syringe.
15. The method of claim 14 , wherein the housing and the syringe collectively define a luer lock.